FDA.reportPublic FDA data

zolpidem tartrate 5 MG Sublingual Tablet [Edluar]

RxCUI
836649
RxNorm name
zolpidem tartrate 5 MG Sublingual Tablet [Edluar]
Display name
zolpidem tartrate 5 MG Sublingual Tablet [Edluar]
Full name
zolpidem tartrate 5 MG Sublingual Tablet [Edluar]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:11

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
EdluarZOLPIDEM TARTRATEViatris Specialty LLCa32884d0-85b5-11de-8a39-0800200c9a662022-08-15Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 836649

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
a32884d0-85b5-11de-8a39-0800200c9a66zolpidem tartrate 5 MG Sublingual Tablet [Edluar]SBD22These highlights do not include all the information needed to use EDLUAR safely and effectively. See full prescribing information for EDLUAR. EDLUAR ® (zolpidem tartrate) sublingual tablets, for oral use, CIV Initial U.S. Approval: 199220220815
a32884d0-85b5-11de-8a39-0800200c9a66Edluar 5 MG Sublingual TabletSY22These highlights do not include all the information needed to use EDLUAR safely and effectively. See full prescribing information for EDLUAR. EDLUAR ® (zolpidem tartrate) sublingual tablets, for oral use, CIV Initial U.S. Approval: 199220220815
a32884d0-85b5-11de-8a39-0800200c9a66EDLUAR 5 MG Sublingual TabletPSN22These highlights do not include all the information needed to use EDLUAR safely and effectively. See full prescribing information for EDLUAR. EDLUAR ® (zolpidem tartrate) sublingual tablets, for oral use, CIV Initial U.S. Approval: 199220220815